Saad Mark E 4
4 · Axsome Therapeutics, Inc. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-27+1,519→ 1,519 totalExercise: $84.00From: 2024-02-27Exp: 2034-02-26→ Common Stock (1,519 underlying)
Footnotes (1)
- [F1]Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.